ArticleMedical oncology (Northwood, London, England)2016

STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population.

Kazuhiro Yamamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.